Cyclooxygenase
Products Related to Cyclooxygenase(517)
- GC48157tetranor-PGEM-d6CAS: 1240398-16-6Purity: >99.00%
An internal standard for the quantification of tetranorPGEM
- GC48160TG11-77 (hydrochloride)CAS: 2550393-38-7Purity: >98.00%
A neuropeptide with diverse biological activities
- GC48176Thromboxane B2-d4CAS: 1346112-79-5Purity: >99.00%
An internal standard for the quantification of thromboxane B 2 d 4
- GC48194trans-Resveratrol-d4CAS: 1089051-56-8Purity: >99.00%
An internal standard for the quantification of trans-resveratrol
- GC48202Treprostinil (diethanolamine salt)CAS: 830354-48-8Purity: >98.00%
La diéthanolamine de tréprostinil (UT-15C) est un puissant agoniste de EP2, DP1 et IP avec des valeurs Ki de 3,6, 4,4, 32,1, 212, 826, 2505 et 4680 nM pour EP2, DP1, IP, EP1, EP4, EP3 et FP, respectivement .
- GC48508(4-Carboxybutyl-d4)triphenylphosphonium (bromide)CAS: 42932-63-8Purity: >99.00%
An internal standard for the quantification of (4-carboxybutyl)triphenylphosphonium
- GC48827Flufenamic Acid-d4CAS: 1185071-99-1Purity: >99.00%
An internal standard for the quantification of flufenamic acid
- GC4903615-(6-nitroxyhexanoyl)-17-phenyl trinor Prostaglandin F2αCAS: 1194396-71-8Purity: >98.00%
A nitric oxide-donating derivative of 17-phenyl trinor prostaglandin F 2α
- GC49054Oxaprozin-d5CAS: 2933758-40-6Purity: >99.00%
An internal standard for the quantification of oxaprozin
- GC49128Phenylbutazone-d9CAS: 1189479-75-1Purity: >99.00%
An internal standard for the quantification of phenylbutazone
- GC49316O-Desmethyl-N-deschlorobenzoyl IndomethacinCAS: 50995-53-4Purity: >95.00%
A metabolite of indomethacin
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC48157 | tetranor-PGEM-d6 | 1240398-16-6 | >99.00% | |
An internal standard for the quantification of tetranorPGEM | ||||
| GC48158 | tetranor-Prostaglandin E1 | 23923-84-4 | >95.00% | |
A metabolite of PGE 1 and PGE 2 | ||||
| GC48160 | TG11-77 (hydrochloride) | 2550393-38-7 | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48176 | Thromboxane B2-d4 | 1346112-79-5 | >99.00% | |
An internal standard for the quantification of thromboxane B 2 d 4 | ||||
| GC48177 | Thromboxane B2-d9 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48194 | trans-Resveratrol-d4 | 1089051-56-8 | >99.00% | |
An internal standard for the quantification of trans-resveratrol | ||||
| GC48202 | Treprostinil (diethanolamine salt) | 830354-48-8 | >98.00% | |
La diéthanolamine de tréprostinil (UT-15C) est un puissant agoniste de EP2, DP1 et IP avec des valeurs Ki de 3,6, 4,4, 32,1, 212, 826, 2505 et 4680 nM pour EP2, DP1, IP, EP1, EP4, EP3 et FP, respectivement . | ||||
| GC48447 | TAS 205 | 1584160-52-0 | >98.00% | |
An inhibitor of H-PGDS | ||||
| GC48508 | (4-Carboxybutyl-d4)triphenylphosphonium (bromide) | 42932-63-8 | >99.00% | |
An internal standard for the quantification of (4-carboxybutyl)triphenylphosphonium | ||||
| GC48677 | Sulindac-d3 | - | >99.00% | |
| GC48739 | (±)15-HETE-d8 | 2525175-31-7 | >99.00% | |
| GC48827 | Flufenamic Acid-d4 | 1185071-99-1 | >99.00% | |
An internal standard for the quantification of flufenamic acid | ||||
| GC49036 | 15-(6-nitroxyhexanoyl)-17-phenyl trinor Prostaglandin F2α | 1194396-71-8 | >98.00% | |
A nitric oxide-donating derivative of 17-phenyl trinor prostaglandin F 2α | ||||
| GC49054 | Oxaprozin-d5 | 2933758-40-6 | >99.00% | |
An internal standard for the quantification of oxaprozin | ||||
| GC49098 | Olsalazine-13C6 | - | >98.00% | |
An internal standard for the quantification of olsalazine | ||||
| GC49119 | 5-hydroxy Flunixin | 75369-61-8 | >95.00% | |
A metabolite of flunixin | ||||
| GC49128 | Phenylbutazone-d9 | 1189479-75-1 | >99.00% | |
An internal standard for the quantification of phenylbutazone | ||||
| GC49130 | Hydroxy Celecoxib | 170571-00-3 | >95.00% | |
An inactive metabolite of celecoxib | ||||
| GC49152 | Celecoxib Carboxylic Acid | 170571-01-4 | >95.00% | |
An inactive metabolite of celecoxib | ||||
| GC49156 | Etodolac Acyl Glucuronide | 79541-43-8 | >90.00% | |
A phase II metabolite of etodolac | ||||
| GC49179 | (S)-O-Desmethyl Naproxen | 52079-10-4 | >98.00% | |
A metabolite of (S)-naproxen | ||||
| GC49183 | 6-hydroxy Etodolac | 101901-06-8 | >90.00% | |
A metabolite of etodolac | ||||
| GC49315 | 5-hydroxy Indomethacin | 2504-32-7 | >98.00% | |
A metabolite of indomethacin | ||||
| GC49316 | O-Desmethyl-N-deschlorobenzoyl Indomethacin | 50995-53-4 | >95.00% | |
A metabolite of indomethacin | ||||